Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration

Autor: Stephen J. Freedland, Rickard Sandin, Janvi Sah, Birol Emir, Qiao Mu, Anna Ratiu, Agnes Hong, Lucile Serfass, Scott T. Tagawa

Publikováno v: Cancer Medicine, Vol 10, Iss 23, Pp 8570-8580 (2021)

Abstract Background Limited real‐world data exist on treatment patterns and outcomes in patients with metastatic castration‐sensitive prostate cancer (mCSPC). Methods A retrospective cohort study was conducted, using the Veterans Health Administr

Externí odkaz: https://doaj.org/article/8572d3bbe63c4a15a397dc787e63798d

Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice

Autor: Limin Liu, Jungyeon Choi, Jammbe Z Musoro, Willi Sauerbrei, Cecilie Delphin Amdal, Ahu Alanya, Yolanda Barbachano, Joseph C Cappelleri, Ragnhild Sørum Falk, Mallorie H Fiero, Antoine Regnault, Jaap C Reijneveld, Rickard Sandin, Doranne Thomassen, Satrajit Roychoudhury, Els Goetghebeur, Saskia le Cessie, Olalekan Lee Aiyegbusi, Ethan Basch, Melanie Calvert, Alicyn Campbell, Joseph Cappelleri, Samantha Cruz Rivera, Mallorie Fiero, Rajesh Kamalakar, Karen Keating, Paul Kluetz, Geert Molenberghs, Jammbe Musoro, David Ness, Khadija Rantell, Jaap Reijneveld, Gerhard Rumpold, Alexander Russell-Smith, Claudia Rutherford, Kavita Sail, Maxime Sasseville, Anja Schiel, Michael Schlichting, Kathy Soltys, Ragnhild Sorum Falk, Yun Su, Silene ten Seldam, Kelly Van Lancker

Publikováno v: Liu, L, Choi, J, Musoro, J Z, Sauerbrei, W, Amdal, C D, Alanya, A, Barbachano, Y, Cappelleri, J C, Falk, R S R, Fiero, M H, Regnault, A, Reijneveld, J C, SISAQOL-IMI Work Package 3, Sandin, R, Thomassen, D, Roychoudhury, S, Goetghebeur, E & le Cessie, S 2023, ' Single-arm studies involving patient-reported outcome data in oncology : a literature review on current practice ', The Lancet Oncology, vol. 24, no. 5, pp. e197-e206 . https://doi.org/10.1016/S1470-2045(23)00110-9

Patient-reported outcomes (PROs) are increasingly used in single-arm cancer studies. We reviewed 60 papers published between 2018 and 2021 of single-arm studies of cancer treatment with PRO data for current practice on design, analysis, reporting, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e7ed9525c5e6a37dc74e0361c03e4d
https://doi.org/10.1016/s1470-2045(23)00110-9

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures

Autor: Madeline Pe, Ahu Alanya, Ragnhild Sorum Falk, Cecilie Delphin Amdal, Kristin Bjordal, Jane Chang, Paul Cislo, Corneel Coens, Linda Dirven, Rebecca M Speck, Kristina Fitzgerald, Jayne Galinsky, Johannes M Giesinger, Bernhard Holzner, Saskia Le Cessie, Daniel O'Connor, Kathy Oliver, Vivek Pawar, Chantal Quinten, Michael Schlichting, Jinma Ren, Satrajit Roychoudhury, Martin J B Taphoorn, Galina Velikova, Lisa M Wintner, Ingolf Griebsch, Andrew Bottomley, Cat Bui, Nnadozie Emechebe, Rajesh Kamalakar, Elektra Papadopoulos, Kavita Sail, Rohini Sen, Sean C Turner, Kim Cocks, Jaap Reijneveld, Christoph Gerlinger, Karen Keating, Yun Su, Birgit Wolf, Miaomiao Ge, Anders Ingelgaard, Barbara Peil, Maarten Voorhaar, Brendon Wong, Gracia Dekanic Arbanas, Karin Kuljanic, Duska Petranovic, Ivana Rede, Juan Arraras, Stephen Joel Coons, Sonya Eremenco, Lindsey Murray, Bryce Reeve, Corinne De Vries, Ralf Herold, Francesco Pignatti, Abigirl Machingura, Francesca Martinelli, Jammbe Musoro, Martine Piccart, Jorge Barriuso, Nathan Cherny, Ourania Dafni, Elisabeth De Vries, Bishal Gyawali, Barbara Kiesewetter, Sjoukje Oosting, Felipe Roitberg, Gerhard Rumpold, Felix Schoepf, Michael Tschuggnall, Jennifer Black, Maxime Sasseville, Katherine Soltys, Montserrat Ferrer, Olatz Garin, Gemma Vilagut, Christoph Schürmann, Stefanie Thomas, Beate Wieseler, Claire Snyder, Ariel Alonso Abad, Kris Bogaerts, Febe Brackx, Geert Molenberghs, Geert Verbeke, Cristián Frigolett Catalan, Jan Choi, Doranne Thomassen, Jan Geissler, Willi Sauerbrei, Franziska Gross, Micha Johannes Pilz, Yolanda Barbachano, Lisa Campbell, Khadija Rantell, Gregoire Desplanques, Antoine Regnault, Kate Morgan, Ananda Plate, Silene ten Seldam, Mitsumi Terada, Junki Mizusawa, Sandra Mitchell, Ashley Wilder Smith, Tove Ragna Reksten, Anja Schiel, Kenth Louis Hansen Joseph, Alicyn Campbell, Joseph Cappelleri, Patrizia de Besi, Alexander Russell-Smith, Rickard Sandin, Carla Mamolo, Michael Brundage, Dongsheng Tu, Mogens Groenvold, Morten Petersen, Charlie Cleeland, Lori Williams, Xin Shelley Wang, Jolie Ringash, Melanie Calvert, Samantha Cruz Rivera, Olalekan Lee Aiyegbusi, Els Goetghebeur, Limin Liu, Kelly Van Lancker, Florien Boele, Alexandra Gilbert, Rosemary Peacock, Ethan Basch, Madeleine King, Claudia Rutherford, Vishal Bhatnagar, Mallorie Fiero, Erica Horodniceanu, Laura Lee Johnson, Paul Kluetz, Lisa Rodriguez

Publikováno v: SISAQOL-IMI Consortium & et al. 2023, ' Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures ', Lancet Oncology, vol. 24, no. 6, pp. e270-e283 . https://doi.org/10.1016/S1470-2045(23)00157-2

Patient-reported outcomes (PROs), such as symptoms, functioning, and other health-related quality-of-life concepts are gaining a more prominent role in the benefit–risk assessment of cancer therapies. However, varying ways of analysing, presenting,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9c09b5d5b8e72fb9e0a912f8763409
https://research.manchester.ac.uk/en/publications/0a737d16-9496-4acc-8a64-8e7eca001879

Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Autor: Stephen J. Freedland, Krishnan Ramaswamy, Ahong Huang, Rickard Sandin, Jack Mardekian, Neil M. Schultz, Nora Janjan, Daniel J. George

Publikováno v: Clinical Genitourinary Cancer.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a36e39fb5f965db2a094b708561291c7
https://doi.org/10.1016/j.clgc.2023.01.003

The patient’s perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050

Autor: Rickard Sandin, Arlene Reisman, Jean Paty, Yi-Long Wu, Jesus Corral, R. Linke, Seiji Niho, Tony Mok, Maria Rita Migliorino, Adam Pluzanski, Ki Hyeong Lee, Kazuhiko Nakagawa, Xiangdong Zhou, Ying Cheng, Oren Meyers

Publikováno v: Future Oncology. 17:783-794

Aim: Patient-reported symptoms, functioning and overall quality of life (QoL) were compared between dacomitinib and gefitinib in ARCHER 1050. Patients & methods: Patients (n = 448) with advanced EGFR mutation-positive non-small-cell lung cancer compl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::035e07b22fdec5be9e26c6b75dbc7904
https://doi.org/10.2217/fon-2020-0888